Evaluation of the German biographic screening interview for fetal alcohol spectrum disorder (BSI-FASD).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 11 04 2020
accepted: 10 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 15 12 2021
Statut: epublish

Résumé

Alcohol consumption during pregnancy may lead to permanent damage in the offspring, including fetal alcohol spectrum disorders (FASD), which have an estimated prevalence of 1-8% worldwide. In adulthood, diagnosing FASD is time-consuming and costly. This study aimed to evaluate the discriminatory power of a German screening instrument for FASD in adults-the biographic screening interview (BSI-FASD). In an open-label comparative cohort study wherein a one-time survey was administered per participant, we compared 22 subjects with confirmed FASD with control groups of 15 subjects diagnosed with attention deficit hyperactivity disorder (ADHD), 20 subjects with alcohol or opiate dependence, 18 subjects with depression, and 31 controls without prenatal alcohol exposure. The BSI-FASD was found to be resource-efficient, user-friendly, comprehensible, and easily applicable. It provided an overall good convergent and discriminant validity with a sensitivity of 0.77 (adapted 0.86) and specificities between 0.70 and 1.00. The BSI-FASD subdomains differed in their power to differentiate FASD from the groups. This study established that the BSI-FASD is an efficient instrument to screen adults with suspected FASD. The BSI-FASD may facilitate future diagnostic evaluation and thereby contribute to improved treatment of affected individuals.

Identifiants

pubmed: 33664281
doi: 10.1038/s41598-021-83942-2
pii: 10.1038/s41598-021-83942-2
pmc: PMC7933170
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5233

Références

Can J Psychiatry. 2019 Mar;64(3):161-163
pubmed: 30835512
Lancet. 1973 Jun 9;1(7815):1267-71
pubmed: 4126070
Eur Arch Psychiatry Clin Neurosci. 2019 Sep;269(6):681-687
pubmed: 30353263
J Popul Ther Clin Pharmacol. 2011;18(3):e494-9
pubmed: 22124027
Nervenarzt. 2004 Sep;75(9):888-95
pubmed: 15378249
Prog Neurobiol. 2019 Jan;172:84-103
pubmed: 29886148
Acta Psychiatr Scand. 2017 Jul;136(1):96-107
pubmed: 28383757
Alcohol Res. 2015;37(1):97-108
pubmed: 26259091
Nervenarzt. 2002 Sep;73(9):830-8
pubmed: 12215873
Addict Biol. 2020 Mar;25(2):e12866
pubmed: 31859437
Alcohol Alcohol. 2001 Mar-Apr;36(2):147-59
pubmed: 11259212
Nervenarzt. 2008 Mar;79(3):320-7
pubmed: 18210051
Lancet Neurol. 2019 Aug;18(8):760-770
pubmed: 31160204
Birth Defects Res C Embryo Today. 2016 Jun;108(2):174-80
pubmed: 27297122
CMAJ. 2016 Feb 16;188(3):191-197
pubmed: 26668194
Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):261-72
pubmed: 17640043
Alcohol Alcohol. 2019 Jan 9;54(5):545-550
pubmed: 31216355
Prog Neurobiol. 2012 Jan;96(1):136-63
pubmed: 22115850
JAMA Pediatr. 2017 Oct 1;171(10):948-956
pubmed: 28828483
Int J Soc Psychiatry. 2016 Mar;62(2):156-66
pubmed: 26619849
Pediatrics. 2015 Jan;135(1):e52-8
pubmed: 25535260
Eur J Health Econ. 2017 Jun;18(5):575-585
pubmed: 27279344

Auteurs

Michael Widder (M)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany. michael.widder@uk-erlangen.de.

Luisa Mierzwa (L)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.

Lina Schwerg (L)

Sonnenhof e.V., Berlin, Germany.

Henrike Schecke (H)

Addiction Research Group, Department of Psychiatry and Psychotherapy, LVR-Klinikum Essen, Hospital of the University of Duisburg-Essen, Essen, Germany.

Johannes Kornhuber (J)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.

Polyxeni Bouna-Pyrrou (P)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.

Jan Malte Bumb (JM)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Feuerlein Center on Translational Addiction Medicine (FCTS), Heidelberg University, Mannheim, Germany.

Tanja Richter-Schmidinger (T)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.

Bernd Lenz (B)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.
Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Feuerlein Center on Translational Addiction Medicine (FCTS), Heidelberg University, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH